Citizen Health & Safety

OMB Watch Applauds Obama's Revocation of Bush-Era Executive Order on Regulatory Review

WASHINGTON, Feb. 4, 2009—OMB Watch applauds President Barack Obama’s decision to undo one of former President George W. Bush’s attempts to paralyze the regulatory process. In an executive order published in today's issue of the Federal Register, Obama revokes Executive Order 13422 and all implementing guidelines and documents.

read in full

Obama Asks for Recommendations on Regulatory Process, OIRA

Feb 3, 2009 by Matthew Madia

President Barack Obama is asking federal agencies to reform the process for writing new regulations. In a Jan. 30 memo, published in today's Federal Register, Obama instructs Director of the White House Office of Management and Budget Peter Orszag, in consultation with agency officials, to formulate a set of recommendations for transforming the government's rule-writing process. Obama wants the recommendations within 100 days.

read in full

Action on Midnight Rules Switches to Agencies

Jan 29, 2009 by Matthew Madia

One of the first tasks on the to-do list for new Obama administration agency heads will be dealing with the midnight regulations left by the Bush administration. The White House has likely said all its going to say on the issue (more here), but the majority of Bush's regulations are still unaddressed.

read in full

What is the Obama Agenda for Bush-Era Regulations?

Just hours after President Barack Obama took the oath of office on Jan. 20, new White House Chief of Staff Rahm Emanuel issued a memo setting out the Obama administration's policy for dealing with some regulations left by the administration of President George W. Bush. The Emanuel memo puts a freeze on all regulations still in the pipeline and gives agencies leeway to deal with those Bush-era regulations already finalized but not yet being implemented. However, the memo does not address most of the controversial regulations finalized by the Bush administration in its last days; these rules are already in effect and impacting the nation.

read in full

GAO Report Highlights High-Risk Areas

The Government Accountability Office (GAO) released its latest report to Congress Jan. 22 highlighting the wide range of high-risk areas in government that it urges the new Congress and administration to address. The report updates the areas already on GAO's list and adds three new high-risk areas: the outdated financial regulatory system, medical product oversight and regulation, and toxic chemical assessment.

read in full

Lobbyists Creeping into Obama Administration

Jan 28, 2009 by Matthew Madia

cash stacksPresident Obama's new ethics platform has already sprung some serious leaks. In spite of an executive order aimed to stem the influence of lobbyists in the Obama administration, former lobbyists are finding their way into top posts, according to the National Journal.

read in full

States Try Again to Regulate GHG Emissions from Cars

Jan 23, 2009 by Matthew Madia

California is once again seeking federal approval for its plans to regulate greenhouse gas emissions from vehicles. If the Environmental Protection Agency gives California the green light, 17 other states representing almost half of the U.S. auto market are expected to follow suit.

read in full

After Midnight

The Bush administration rushed out a host of problematic regulations in its final months. Many of these "midnight" regulations actually represent deregulatory actions that weaken or eliminate safeguards protecting health, safety, the environment, and the public's general welfare. This report, produced by OMB Watch and the Center for American Progress, explores how those rules came to be and what the Obama administration and Congress may be able to do about them.

read in full

Bush to Leave Damaging Legacy, New Report Shows

Jan 16, 2009 by Matthew Madia

OMB Watch released a report Jan. 14 cataloguing and explaining the damage done by eight years of George W. Bush's presidency.

read in full

In Boon to Drug Industry, FDA Creates Marketing Loophole

Jan 15, 2009 by Matthew Madia

The Food and Drug Administration has made a controversial policy change that will allow pharmaceutical companies to market unapproved, or "off-label," uses of drugs. The policy, coming in the form of a guidance document, will allow industry representatives to use journal studies to persuade doctors to prescribe FDA-approved drugs for unapproved uses. More from Reuters:

read in full

Pages

  • ©2025 Project On Government Oversight
  • All Rights Reserved.
  • This an archive site of the materials produced by the Center for Effective Government (formerly OMB Watch) and is maintained by the Project On Government Oversight.